Cargando…
Regulation of expression of drug-metabolizing enzymes by oncogenic signaling pathways in liver tumors: a review
Mutations in genes encoding key players in oncogenic signaling pathways trigger specific downstream gene expression profiles in the respective tumor cell populations. While regulation of genes related to cell growth, survival, and death has been extensively studied, much less is known on the regulat...
Autores principales: | Braeuning, Albert, Schwarz, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6976994/ https://www.ncbi.nlm.nih.gov/pubmed/31993310 http://dx.doi.org/10.1016/j.apsb.2019.06.013 |
Ejemplares similares
-
Chemically induced mouse liver tumors are resistant to treatment with atorvastatin
por: Braeuning, Albert, et al.
Publicado: (2014) -
Metabolism-Disrupting Chemicals Affecting the Liver: Screening, Testing, and Molecular Pathway Identification
por: Fritsche, Kristin, et al.
Publicado: (2023) -
Oncogenic regulation of tumor metabolic reprogramming
por: Tarrado-Castellarnau, Míriam, et al.
Publicado: (2016) -
Oncogenic
KRAS
Drives Metabolic Vulnerabilities by Directly Regulating Metabolic Enzymes in Cancer
por: Zhang, Liyi
Publicado: (2020) -
The Connection of Azole Fungicides with Xeno-Sensing Nuclear Receptors, Drug Metabolism and Hepatotoxicity
por: Marx-Stoelting, Philip, et al.
Publicado: (2020)